CD44 and cancer: While Osteopontin produced by TAMs contributes to blunting the adaptive immune response to cancer, it has a wide range of cancer cell-autonomous functions including the promotion of an epithelial-to-mesenchymal transition (EMT) linked to increased cancer stem cell properties and metastatic proclivity downstream of its interactions with CD44 and integrin αvβ342,44.